Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stump

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Critical Care (London, England)|July 11, 2020
The effect of short-course antibiotics on the resistance profile of colonizing gut bacteria in the ICU: a prospective cohort studyChristian Munck, Ravi U Sheth, Edward Cuaresma, et al.
Arthritis Research & Therapy|April 23, 2011
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritisKristine L Stump, Lily D Lu, Pawel Dobrzanski, et al.
Circulation|November 5, 1999
Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmiaJ J Lynch, M S Houle, G L Stump, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2011
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2Lily D Lu, Kristine L Stump, Nate H Wallace, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosisJ J Cook, S J Gardell, M A Holahan, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Journal of Medicinal Chemistry|November 28, 2006
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillationB Wesley Trotter, Kausik K Nanda, Nathan R Kett, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Critical Care (London, England)|July 11, 2020
The effect of short-course antibiotics on the resistance profile of colonizing gut bacteria in the ICU: a prospective cohort studyChristian Munck, Ravi U Sheth, Edward Cuaresma, et al.
Arthritis Research & Therapy|April 23, 2011
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritisKristine L Stump, Lily D Lu, Pawel Dobrzanski, et al.
Circulation|November 5, 1999
Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmiaJ J Lynch, M S Houle, G L Stump, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2011
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2Lily D Lu, Kristine L Stump, Nate H Wallace, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosisJ J Cook, S J Gardell, M A Holahan, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Journal of Medicinal Chemistry|November 28, 2006
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillationB Wesley Trotter, Kausik K Nanda, Nathan R Kett, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Pageof 7